GL1X · GenesisL1 explorer

Research workbench

T-cell receptor beta chain complexed with SEC3 superantigen

Analyse T-cell receptor beta chain complexed with SEC3 superantigen in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1JCK
Type
protein
Length
954 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
14.3.D T cell antigen receptor; Staphylococcal enterotoxin C3
UniProt
P0A0L5
Pockets
8 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C14.3.D T cell antigen receptorprotein2387% helix, 46% strand—
B, DStaphylococcal enterotoxin C3protein23917% helix, 33% strandP0A0L5

Pockets

8 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19280.800.8294empty
27650.790.8380empty
32990.630.8043empty
41590.590.8329empty
52140.550.7929empty

Interfaces

5 interfaces between chains.

  • A–B · 656 Ų buried · 14 hydrogen bonds · protein-protein
  • C–D · 656 Ų buried · 14 hydrogen bonds · protein-protein
  • A–C · 623 Ų buried · 4 hydrogen bonds · protein-protein
  • A–D · 480 Ų buried · 5 hydrogen bonds · protein-protein
  • B–C · 480 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 1JCK · T-cell receptor beta chain complexed with SEC3 superantigen · the same entry in another collection · chain A against A, TM-score 1.00
  • P0A0L5 · AlphaFold monomer V2.0 prediction for enterotoxin type C-3 (P0A0L5) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.